Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Attention Deficit Disorder with Hyperactivity

1-(3-chlorophenyl)piperazine has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nowak, P1
Bortel, A1
Dabrowska, J1
Oswiecimska, J1
Drosik, M1
Kwiecinski, A1
Opara, J1
Kostrzewa, RM1
Brus, R1

Other Studies

1 other study available for 1-(3-chlorophenyl)piperazine and Attention Deficit Disorder with Hyperactivity

ArticleYear
Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.
    Neurotoxicity research, 2007, Volume: 11, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5,6-Dihydroxytryptamine; Age Factors; Amphetamine; Animals; Attentio

2007